ahlam1399
04-07-2016, 02:09 AM
U.S. drug developer Raptor Pharmaceuticals explores sale -sources
April 6 (Reuters) - Raptor Pharmaceutical Corp, which develops ***** that treat orphan diseases, is in discussions with investment banks to hire a financial adviser to explore a potential sale, according to people familiar with the matter.
http://rc.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/rc/1/rc.htm)
http://rc.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/rc/2/rc.htm)
http://rc.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/rc/3/rc.htm)
http://da.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/a2.img (http://da.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/ach.img (http://adchoice.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/ach.htm)http://pi.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/a2t.imghttp://pi2.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4ec4a7cc/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=27DYt-aw4Q4:NVRTHbWjx5g:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=27DYt-aw4Q4:NVRTHbWjx5g:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=27DYt-aw4Q4:NVRTHbWjx5g:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=27DYt-aw4Q4:NVRTHbWjx5g:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=27DYt-aw4Q4:NVRTHbWjx5g:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/27DYt-aw4Q4
April 6 (Reuters) - Raptor Pharmaceutical Corp, which develops ***** that treat orphan diseases, is in discussions with investment banks to hire a financial adviser to explore a potential sale, according to people familiar with the matter.
http://rc.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/rc/1/rc.htm)
http://rc.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/rc/2/rc.htm)
http://rc.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/rc/3/rc.htm)
http://da.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/a2.img (http://da.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/ach.img (http://adchoice.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/ach.htm)http://pi.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/a2t.imghttp://pi2.feedsportal.com/r/247397078160/u/49/f/654213/c/35217/s/4ec4a7cc/sc/28/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4ec4a7cc/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=27DYt-aw4Q4:NVRTHbWjx5g:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=27DYt-aw4Q4:NVRTHbWjx5g:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=27DYt-aw4Q4:NVRTHbWjx5g:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=27DYt-aw4Q4:NVRTHbWjx5g:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=27DYt-aw4Q4:NVRTHbWjx5g:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/27DYt-aw4Q4